# RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

> **NCT03118986** · PHASE2 · RECRUITING · sponsor: **The Hospital for Sick Children** · enrollment: 200 (estimated)

## Conditions studied

- Vomiting in Infants and/or Children
- Nausea
- Hematopoietic System--Cancer
- Oncology

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03118986
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-08-10
- **Primary completion:** 2026-03
- **Final completion:** 2026-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118986, "RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03118986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*